Old Web
English
Sign In
Acemap
>
authorDetail
>
Bernd Frye
Bernd Frye
Fibrosis
Myeloid leukemia
Imatinib
Medicine
imatinib mesylate
3
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia
2007
Leukemia
Guntram Buesche
A Ganser
Brigitte Schlegelberger
N. von Neuhoff
Dorothea Gadzicki
Hartmut Hecker
Oliver Bock
Bernd Frye
Hans-Heinrich Kreipe
Show All
Source
Cite
Save
Citations (51)
In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients.
2006
Blood
Guntram Buesche
Rüdiger Hehlmann
Arnold Ganser
Hartmut Hecker
Andreas Hochhaus
Hermann Heimpel
B. Heinze
Claudia Schoch
Dorothea Gadzicki
Martin C. Mueller
Nils von Neuhoff
Susanne Schnittger
Brigitte Schlegelberger
Bernd Frye
Axel Georgii
Hans Kreipe
Show All
Source
Cite
Save
Citations (1)
Emerging Marrow Fibrosis Is an Early Indicator of Imatinib Failure and Shortened Survival Time in CML Independent of Hematologic, Cytogenetic and Molecular Response.
2005
Blood
Guntram Buesche
R. Hehlmann
Arnold Ganser
Hartmut Hecker
Mathias Freund
Hermann Heimpel
B. Heinze
Dorothea Gadzicki
Brigitte Schlegelberger
Christa Fonatsch
Bernd Frye
Andreas Tobler
Axel Georgii
Hans Kreipe
Show All
Source
Cite
Save
Citations (0)
1